First Tracks Biotherapeutics (TRAX) News
NASDAQ: TRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
31.85-0.16 (-0.50%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
TRAX news summary
We found 1 recent headline mentioning First Tracks Biotherapeutics (TRAX): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. For price context, TRAX is down 0.50% at $31.85. The most recent story, "First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026", was published by GlobeNewswire on Oct 11, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology